KEGG   DRUG: Eluvixtamab
Entry
D12152                      Drug                                   
Name
Eluvixtamab (USAN)
Formula
C2396H3620N658O764S15
Exact mass
54314.0451
Mol weight
54347.33
Sequence
QVQLVQSGAE VKKPGESVKV SCKASGYTFT NYGMNWVKQA PGQGLEWMGW NTYTGEPTY
ADKFQGRVTM TTDTSTSTAY MEIRNLGGDD TAVYYCARWS WSDGYYVYFD YWGQGTSVTV
SSGGGGSGGG GSGGGGSDIV MTQSPDSLTV SLGERTTINC KSSQSVLDSS TNKNSLAWYQ
QKPGQPPKLL LSWASTRESG IPDRFSGSGS GTDFTLTIDS PQPEDSATYY CQQSAHFPIT
FGQGTRLEIK SGGGGSEVQL VESGGGLVQP GGSLKLSCAA SGFTFNKYAM NWVRQAPGKG
LEWVARIRSK YNNYATYYAD SVKDRFTISR DDSKNTAYLQ MNNLKTEDTA VYYCVRHGNF
GNSYISYWAY WGQGTLVTVS SGGGGSGGGG SGGGGSQTVV TQEPSLTVSP GGTVTLTCGS
STGAVTSGNY PNWVQQKPGQ APRGLIGGTK FLAPGTPARF SGSLLGGKAA LTLSGVQPED
EAEYYCVLWY SNRWVFGGGT KLTVLHHHHH H
(Disulfide bridge: 22-96, 160-231, 278-354, 418-486)
  Type
Peptide
Efficacy
Antineoplastic
  Type
Monoclonal antibody
Comment
Treatment of acute myeloid leukemia (AML)
Target
CD33 (SIGLEC3) [HSA:945] [KO:K06473]
  Pathway
hsa04640  Hematopoietic cell lineage
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Cell adhesion molecules: Ig superfamiy
   SIGLEC family
    CD33 (SIGLEC3)
     D12152  Eluvixtamab (USAN)
Other DBs
PubChem: 497620565
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system